Abstract:Qingcheng Song, 1, 2, &ast Yiran Zhang, 3, &ast Hongzhi Hu, 4, &ast Xuemei Yang, 5 Xin Xing, 1, 2 Jianhua Wu, 6 Yanbin Zhu, 1, 2 Yingze Zhang 1, 2 1 Department of Orthopaedic Surgery, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 2 Orthopaedic Institution of Hebei Province, Shijiazhuang, Hebei, People's Republic of China; 3 School of Medicine, Nankai University, Tianjin, People's Republic of China; 4 Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China; 5 The Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei, People's Republic of China; 6 The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yingze Zhang; Yanbin Zhu, Email ; Introduction: Ferroptosis-driven tumor ablation strategies based on nanotechnology could be achieved by elevating intracellular iron levels or inhibiting glutathione peroxidase 4 (GPX4) activity. However, the intracellular antioxidative defense mechanisms endow tumor cells with ferroptosis resistance capacity. The purpose of this study was to develop a synergistic therapeutic platform to enhance the efficacy of ferroptosis-based tumor therapy. Methods: In this study, a multifunctional nano-catalytic therapeutic platform (mFeB@PDA-FA) based on chemodynamic therapy (CDT) and photothermal therapy (PTT) was developed to effectively trigger ferroptosis in tumor. In our work, iron-based mesoporous Fe 3 O 4 nanoparticles (mFe 3 O 4 NPs) were employed for the encapsulation of L-buthionine sulfoximine (BSO), followed by the modification of folic acid-functionalized polydopamine (PDA) coating on the periphery. Then, the antitumor effect of mFeB@PDA-FA NPs was evaluated using Human OS cells (MNNG/HOS) and a subcutaneous xenograft model of osteosarcoma. Results: mFe 3 O 4 harboring multivalent elements (Fe 2+/3+ ) could catalyze hydrogen peroxide (H 2 O 2 ) into highly cytotoxic &dotOH, while the tumor microenvironment (TME)-responsive released BSO molecules inhibit the biosynthesis of GSH, thus achieving the deactivation of GPX4 and the enhancement of ferroptosis. Moreover, thanks to the remarkable photothermal conversion performance of mFe 3 O 4 and PDA shell, PTT further synergistically enhanced the efficacy of CDT and facilitated ferroptosis. Both in vivo and in vitro experiments confirmed that this synergistic therapy could achieve excellent tumor inhibition effects. Conclusion: The nanotherapeutic platform mFeB@PDA-FA could effectively disrupted the redox homeostasis in tumor cells for boosting ferroptosis through the combination of CDT, PTT and GSH elimination, which provided a new perspective for the treatment of ferroptosis sensitive tumors. Keywords: ferroptosis, chemodynamic therapy, photothermal therapy, Fenton reaction, BSO Graphical Osteosarcoma (OS) is the most common primary malignant bone tumor and the leading cause of cancer-related death in children and adolescents. 1,2 At present, the common treatment methods of OS are surgical resection, systemic chemotherapy and radiotherapy, but the therapeutic approaches are far from satisfactory due to chemotherapy resistance and postoperative distant metastasis. 3–5 Hence, the development of new strategies that combine biomedicine with emerging nanotechnology to find alternative ways to stimulate cell death may overcome the current therapeutic dilemma. 6 Ferroptosis, as a non-apoptotic form of programmed cell death, has received considerable attention due to its unique properties associated with various diseases, including cancer. 7,8 Different from traditional apoptosis and necrosis, ferroptosis is mainly characterized by iron-dependent ROS generation and lipid peroxidation (LPO), which is of great significance for killing tumor cells resistant to necrosis and apoptosis. 9,10 Therefore, the intracellular redox active iron (Fe 2+ ) level is the key elements in the process of inducing ferroptosis, which could catalyze the decomposition of hydrogen peroxide (H 2 O 2 ) in the tumor microenvironment (TME) to generate highly toxic hydroxyl radicals ( ̇OH) based on Fenton reaction and promote the accumulation of lipid peroxides, thus causing damage to the structure and inte -Abstract Truncated-

Spatially Asymmetric Nanoparticles for Boosting Ferroptosis in Tumor Therapy.

Targeted Gsh-Exhausting And Hydroxyl Radical Self-Producing Manganese-Silica Nanomissiles For Mri Guided Ferroptotic Cancer Therapy

Dual GSH-exhausting Sorafenib Loaded Manganese-Silica Nanodrugs for Inducing the Ferroptosis of Hepatocellular Carcinoma Cells.

Enhanced ferroptosis therapy with a "nano-destructor" by disrupting intracellular redox and iron homeostasis

Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy.

Activatable Plasmonic Versatile Nanoplatform for Glutathione-Depletion Augmented Ferroptosis and NIR-II Photothermal Synergistic Therapy

Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy

A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapy

Synergistic hydroxyl radical formation, system XC- inhibition and heat shock protein crosslinking tango in ferrotherapy: A prove-of-concept study of "sword and shield" theory

Highly selective and effective ferroptosis liposomal nanodrugs for synergistic antitumor therapy

A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis

Photothermal Enhanced Polyphenol-Based Nanofibers Ameliorate Catalytic Efficiency of Ferroptosis for Synergistic Tumor Therapy

Hyperthermia/glutathione-triggered ferritin nanoparticles amplify the ferroptosis for synergistic tumor therapy

Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer

Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy

A Biomimetic Nanodrug Self-Assembled from Small Molecules for Enhanced Ferroptosis Therapy

Augment of Ferroptosis with Photothermal Enhanced Fenton Reaction and Glutathione Inhibition for Tumor Synergistic Nano-Catalytic Therapy

Protease‐Activatable Nanozyme with Photoacoustic and Tumor‐Enhanced Magnetic Resonance Imaging for Photothermal Ferroptosis Cancer Therapy

Cyclic Catalysis of Intratumor Fe3+/2+ Initiated by a Hollow Mesoporous Iron Sesquioxide Nanoparticle for Ferroptosis Therapy of Large Tumors

Reactive Oxygen-Primed and Autophagy Inhibition-Sensitized Ferroptosis Combined with Photothermal Ablation for Tumor Therapy

Tumor microenvironments self-activated cascade catalytic nanoscale metal organic frameworks as ferroptosis inducer for radiosensitization